Recent experimental findings suggest that d-amphetamine, a potent central nervous system stimulant, can override learned ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
New research reveals why 'tate-nori' (vertical rhythm) songs boost cardio performance, while 'yoko-nori' (horizontal sway) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback